Compare MATV & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MATV | TKNO |
|---|---|---|
| Founded | 1995 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.9M | 482.7M |
| IPO Year | 1996 | 2021 |
| Metric | MATV | TKNO |
|---|---|---|
| Price | $12.25 | $8.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | ★ 425.4K | 265.7K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | N/A | ★ 43.86 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $40,520,000.00 |
| Revenue This Year | $1.75 | $13.53 |
| Revenue Next Year | $3.32 | $14.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.35 |
| 52 Week Low | $7.07 | $1.91 |
| 52 Week High | $15.48 | $9.48 |
| Indicator | MATV | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 57.20 | 64.98 |
| Support Level | $11.76 | $3.67 |
| Resistance Level | $12.74 | $9.48 |
| Average True Range (ATR) | 0.37 | 0.56 |
| MACD | -0.06 | 0.02 |
| Stochastic Oscillator | 71.21 | 74.81 |
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments, namely Filtration & advanced Materials, focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging, and healthcare solutions.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.